INSIGHTS ON DRUG DEVELOPMENT

• Accelerating The Study Of Viral Infection And Therapeutics

  Explore the utilization of the Organ-Chips for investigating viral infections and expediting the development of new therapeutics.

• Reach Development Goals Faster With Multi-Sample Workflow Technology

  Explore the use of Differential Scanning Calorimetry (DSC) multi-sample technology to analyze a variety of pharmaceutical materials and understand critical information for advancing pharma development.

• Unlock The Power Of Biophysical Tools In Biotherapeutic Development

  Unlock innovation in biotherapeutics with expert insights into DSC and molecular stability. Learn how biophysical techniques can optimize formulations and enhance nucleic acid stability.

• Revolutionizing Drug Discovery From "Undruggables" To AI

  Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.

• Overcoming Challenges To High-Concentration Formulation Development

  3/25/2025

  Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

• The Importance Of Reliable Mixing In ITC Experiments

  5/1/2025

  Explore how Isothermal Titration Calorimetry (ITC) precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new therapeutic strategies.

• Improve The Performance Of Your Small And Large Molecule Medicines

  7/23/2024

  Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

• Enabling Quality By Design

  9/8/2025

  Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

• VEGF Signaling Pathway

  3/24/2025

  In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.